Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Yuan S, Larsson SC
Common uses include skin tone enhancement, immune system strengthening, and reducing oxidative stress
In the pivotal Phase III trial that led to FDA approval, Tesamorelin reduced visceral adipose tissue (deep abdominal fat) by 15.2 percent over 26 weeks compared to a 5 percent increase in placebo
It does not bind to specific receptors or trigger direct hormonal responses in the manner of medications
References to specific securities and their issuers are for illustrative purposes only
Horvei, L
US$ 25.45
US$ 27.44
US$ 28.11
